On the public citation graph
Dendritic cell immunotherapy: mapping the way
0 signed · 940 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/(sici)1097-0215(20000501)86:3<385::aid-ijc13>3.0.co;2-topenalex-snapshot
Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells
inferredcites →https://doi.org/10.1002/1521-4141(2001010)31:10<3026::aid-immu3026>3.0.co;2-hopenalex-snapshot
Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12
inferredcites →https://doi.org/10.1002/eji.1830271209openalex-snapshot
Pro‐inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum‐free conditions
inferredcites →https://doi.org/10.1002/eji.200323676openalex-snapshot
Plasmacytoid dendritic cells prime IFN‐γ‐secreting melanoma‐specific CD8 lymphocytes and are found in primary melanoma lesions
inferredcites →https://doi.org/10.1002/ijc.1323openalex-snapshot
A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection
inferredcites →https://doi.org/10.1002/jcb.10340openalex-snapshot
Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases
inferredcites →https://doi.org/10.1007/s002620050465openalex-snapshot
Immunotherapy of cancer with dendritic-cell-based vaccines
inferredcites →https://doi.org/10.1007/s002620050614openalex-snapshot
Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells
inferredcites →https://doi.org/10.1016/0092-8674(90)90591-2openalex-snapshot
Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response
inferredcites →https://doi.org/10.1016/s0092-8674(01)00448-2openalex-snapshot
Dendritic Cells as Vectors for Therapy
inferredcites →https://doi.org/10.1016/s1074-7613(02)00503-4openalex-snapshot
Antigen-Specific Suppression of a Primed Immune Response by Dendritic Cells Mediated by Regulatory T Cells Secreting Interleukin-10
inferredcites →https://doi.org/10.1016/s1074-7613(03)00113-4openalex-snapshot
Characterization of Dendritic Cells that Induce Tolerance and T Regulatory 1 Cell Differentiation In Vivo
inferredcites →https://doi.org/10.1016/s1471-4906(02)02296-2openalex-snapshot
Immune escape through C-type lectins on dendritic cells
inferredcites →https://doi.org/10.1034/j.1600-065x.2002.18816.xopenalex-snapshot
Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes
inferredcites →https://doi.org/10.1038/89863openalex-snapshot
Dendritic cells: On the move from bench to bedside
inferredcites →https://doi.org/10.1038/ni0104-7openalex-snapshot
Dendritic cells: a journey from laboratory to clinic
inferredcites →https://doi.org/10.1038/ni928openalex-snapshot
Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes
inferredcites →https://doi.org/10.1038/ni962openalex-snapshot
Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo
inferredcites →https://doi.org/10.1038/nm0196-52openalex-snapshot
Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
inferredcites →https://doi.org/10.1038/nm0398-328openalex-snapshot
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
inferredcites →https://doi.org/10.1073/pnas.0306407101openalex-snapshot
T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node
inferredcites →https://doi.org/10.1073/pnas.1533209100openalex-snapshot
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
inferredcites →https://doi.org/10.1073/pnas.231606698openalex-snapshot
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
inferredcites →https://doi.org/10.1084/jem.179.4.1109openalex-snapshot
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
inferredcites →https://doi.org/10.1084/jem.180.1.83openalex-snapshot
Proliferating dendritic cell progenitors in human blood.
inferredcites →https://doi.org/10.1084/jem.189.5.753openalex-snapshot
CD4 T Cells and Their Role in Antitumor Immune Responses
inferredcites →https://doi.org/10.1084/jem.20012100openalex-snapshot
Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells
inferredcites →https://doi.org/10.1084/jem.20021348openalex-snapshot
Route of Immunization with Peptide-pulsed Dendritic Cells Controls the Distribution of Memory and Effector T Cells in Lymphoid Tissues and Determines the Pattern of Regional Tumor Control
inferredcites →https://doi.org/10.1084/jem.20021598openalex-snapshot
Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance
inferredcites →https://doi.org/10.1084/jem.20021908openalex-snapshot
Flexibility of Mouse Classical and Plasmacytoid-derived Dendritic Cells in Directing T Helper Type 1 and 2 Cell Development
inferredcites →https://doi.org/10.1084/jem.20030324openalex-snapshot
Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
inferredcites →https://doi.org/10.1084/jem.20030448openalex-snapshot
Regulation of Dendritic Cell Migration to the Draining Lymph Node
inferredcites →https://doi.org/10.1093/jnci/92.3.205openalex-snapshot
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
inferredcites →https://doi.org/10.1126/science.298.5598.1531bopenalex-snapshot
German Inquiry Finds Flaws, Not Fraud
inferredcites →https://doi.org/10.1172/jci0214364openalex-snapshot
Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors
inferredcites →https://doi.org/10.1172/jci0215962openalex-snapshot
Exploiting dendritic cells to improve vaccine efficacy
inferredcites →https://doi.org/10.1172/jci14364openalex-snapshot
Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors
inferredcites →https://doi.org/10.1172/jci15962openalex-snapshot
Exploiting dendritic cells to improve vaccine efficacy
inferredcites →https://doi.org/10.1172/jci6909openalex-snapshot
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
inferredcites →https://doi.org/10.1172/jci9051openalex-snapshot
Mature dendritic cells boost functionally superior CD8+ T-cell in humans without foreign helper epitopes
inferredcites →https://doi.org/10.1182/blood-2001-11-0097openalex-snapshot
Characterization of human blood dendritic cell subsets
inferredcites →https://doi.org/10.1182/blood.v95.10.3162openalex-snapshot
Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10
inferredcites →https://doi.org/10.1182/blood.v96.3.878openalex-snapshot
In vivo generation of human dendritic cell subsets by Flt3 ligand
inferredcites →https://doi.org/10.4049/jimmunol.165.1.566openalex-snapshot
Flt3-Ligand and Granulocyte Colony-Stimulating Factor Mobilize Distinct Human Dendritic Cell Subsets In Vivo
inferredcites →https://doi.org/10.4049/jimmunol.168.9.4361openalex-snapshot
Matrix Metalloproteinases 9 and 2 Are Necessary for the Migration of Langerhans Cells and Dermal Dendritic Cells from Human and Murine Skin
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.5013530openalex-extracted
Forced Intracellular Degradation of Xenoantigens as a Novel Modality for Cell-Based Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/9780470015902.a0001431.pub2openalex-snapshot
Tumour Antigens Recognized by T Lymphocytes
inferred← citeshttps://doi.org/10.1002/9780470015902.a0001431.pub3openalex-snapshot
Tumour Antigens Recognised by T Lymphocytes
inferred← citeshttps://doi.org/10.1002/9780470025079.chap68.pub2openalex-snapshot
Models for Immunotherapy and Cancer Vaccines
inferred← citeshttps://doi.org/10.1002/9780470688397.ch6openalex-snapshot
The Innate Immune Responses, Adjuvants and Delivery Systems
inferred← citeshttps://doi.org/10.1002/9781119905080.ch4openalex-snapshot
Functionalization Carbon Nanotubes Innovate on Medical Technology
inferred← citeshttps://doi.org/10.1002/9783527610419.ntls0120openalex-snapshot
Nanotechnology for Gene Therapy – HVJ ‐ E Vector
inferred← citeshttps://doi.org/10.1002/9783527619696.ch52openalex-snapshot
Dendritic Cell Subsets as Targets and Vectors for Vaccination
inferred← citeshttps://doi.org/10.1002/9783527619696.ch54openalex-snapshot
Crosspresentation and Loading of Tumor Antigens for Dendritic Cell Vaccination against Cancer
inferred← citeshttps://doi.org/10.1002/9783527692866.ch12openalex-snapshot
Immunological Responses Induced by Carbon Nanotubes Exposed to Skin and Gastric and Intestinal System
inferred← citeshttps://doi.org/10.1002/adfm.202413870openalex-snapshot
Lipopeptide Hydrogel Possesses Adjuvant‐Like Properties for the Delivery of the GPC‐3 Peptide‐derived Antigen
inferred← citeshttps://doi.org/10.1002/adhm.201800837openalex-snapshot
Tumor Lysate‐Loaded Lipid Hybrid Nanovaccine Collaborated with an Immune Checkpoint Antagonist for Combination Immunotherapy
inferred← citeshttps://doi.org/10.1002/adma.201102313openalex-snapshot
Cancer Nanotheranostics: Improving Imaging and Therapy by Targeted Delivery Across Biological Barriers
inferred← citeshttps://doi.org/10.1002/ccr3.1169openalex-snapshot
Complete remission of rare adenocarcinoma of the oropharynx with APCEDEN ® (dendritic cell‐based vaccine): a case report
inferred← citeshttps://doi.org/10.1002/dmrr.1275openalex-snapshot
1,25‐Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo
inferred← citeshttps://doi.org/10.1002/eji.200535443openalex-snapshot
The Shiga toxin B‐subunit targets antigen in vivo to dendritic cells and elicits anti‐tumor immunity
inferred← citeshttps://doi.org/10.1002/eji.200535579openalex-snapshot
IFN‐α‐conditioned dendritic cells are highly efficient in inducing cross‐priming CD8+ T cells against exogenous viral antigens
inferred← citeshttps://doi.org/10.1002/eji.200535616openalex-snapshot
Differential effects of the tryptophan metabolite3‐hydroxyanthranilic acid on the proliferation of human CD8+ T cells induced by TCR triggering or homeostatic cytokines
inferred← citeshttps://doi.org/10.1002/eji.200535742openalex-snapshot
In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice
inferred← citeshttps://doi.org/10.1002/eji.201242478openalex-snapshot
CD 34‐derived dendritic cells transfected ex vivo with HIV ‐ G ag m RNA induce polyfunctional T ‐cell responses in nonhuman primates
inferred← citeshttps://doi.org/10.1002/eji.201445127openalex-snapshot
Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non‐human primates
inferred← citeshttps://doi.org/10.1002/hep.25904openalex-snapshot
Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection
inferred← citeshttps://doi.org/10.1002/ijc.21046openalex-snapshot
Dendritic cells delivered inside human carcinomas are sequestered by interleukin‐8
inferred← citeshttps://doi.org/10.1002/ijc.22377openalex-snapshot
Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA‐mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments
inferred← citeshttps://doi.org/10.1002/ijc.22551openalex-snapshot
Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma
inferred← citeshttps://doi.org/10.1002/ijc.22859openalex-snapshot
Immunotherapy with dendritic cells for prostate cancer
inferred← citeshttps://doi.org/10.1002/ijc.23101openalex-snapshot
Glycan modification of the tumor antigen gp100 targets DC‐SIGN to enhance dendritic cell induced antigen presentation to T cells
inferred← citeshttps://doi.org/10.1002/ijc.23444openalex-snapshot
α‐Galactosylceramide‐loaded, antigen‐expressing B cells prime a wide spectrum of antitumor immunity
inferred← citeshttps://doi.org/10.1002/ijc.26412openalex-snapshot
Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin
inferred← citeshttps://doi.org/10.1002/ijc.31588openalex-snapshot
A new cancer immunotherapy via simultaneous DC‐mobilization and DC‐targeted IDO gene silencing using an immune‐stimulatory nanosystem
inferred← citeshttps://doi.org/10.1002/jbm.a.70107openalex-snapshot
Biomaterial‐Focused Strategies Targeting Dendritic Cells for Autoimmune Disease Treatment
inferred← citeshttps://doi.org/10.1002/jgm.1204openalex-snapshot
Effective transduction by self‐complementary adeno‐associated viruses of human dendritic cells with no alteration of their natural characteristics
inferred← citeshttps://doi.org/10.1002/jgm.1436openalex-snapshot
Dendritic cells lentivirally engineered to overexpress interleukin‐10 inhibit contact hypersensitivity responses, despite their partial activation induced by transduction‐associated physical stress
inferred← citeshttps://doi.org/10.1002/jgm.702openalex-snapshot
Altered intracellular sorting signals do not influence the efficacy of genetic melanoma vaccines incorporating helper determinants in mice
inferred← citeshttps://doi.org/10.1002/jgm.952openalex-snapshot
Evaluation of DNA vaccination with recombinant adenoviruses using bioluminescence imaging of antigen expression: impact of application routes and delivery with dendritic cells
inferred← citeshttps://doi.org/10.1002/jsfa.5733openalex-snapshot
Myricetin attenuates lipopolysaccharide‐stimulated activation of mouse bone marrow‐derived dendritic cells through suppression of IKK/NF‐κB and MAPK signalling pathways
inferred← citeshttps://doi.org/10.1002/marc.202200594openalex-snapshot
Glycopolymer Decorated pH‐Dependent Ratiometric Fluorescent Probe Based on Förster Resonance Energy Transfer for the Detection of Cancer Cells
inferred← citeshttps://doi.org/10.1002/med.20237openalex-snapshot
Immunotherapeutic strategies for cancer treatment: A novel protein transfer approach for cancer vaccine development
inferred← citeshttps://doi.org/10.1002/nbm.1774openalex-snapshot
Detection of prostaglandin E2‐induced dendritic cell migration into the lymph nodes of mice using a 1.5 T clinical MR scanner
inferred← citeshttps://doi.org/10.1002/nbm.2774openalex-snapshot
A large‐scale 19F MRI‐based cell migration assay to optimize cell therapy
inferred← citeshttps://doi.org/10.1002/pbc.21246openalex-snapshot
Phenotypic and functional characterization of mature dendritic cells from pediatric cancer patients
inferred← citeshttps://doi.org/10.1002/prca.200900162openalex-snapshot
Understanding dendritic cell biology and its role in immunological disorders through proteomic profiling
inferred← citeshttps://doi.org/10.1002/smll.200701059openalex-snapshot
Carbon Nanotubes Conjugated to Tumor Lysate Protein Enhance the Efficacy of an Antitumor Immunotherapy
inferred← citeshttps://doi.org/10.1002/smll.200800582openalex-snapshot
Biocompatible Polymer‐Nanoparticle‐Based Bimodal Imaging Contrast Agents for the Labeling and Tracking of Dendritic Cells
inferred← citeshttps://doi.org/10.1007/0-387-32829-7_5openalex-snapshot
Regulation of T Cell-Dependent Humoral Immunity Through CD137 (4-1BB) Mediated Signals
inferred← citeshttps://doi.org/10.1007/978-0-387-33785-2_5openalex-snapshot
Adjuvants, Dendritic Cells, and Cytokines: Strategies for Enhancing Vaccine Efficacy
inferred← citeshttps://doi.org/10.1007/978-0-387-33785-2_6openalex-snapshot
Ex Vivo–Generated Dendritic Cells for ClinicalTrials versus In Vivo Targeting to Dendritic Cells: Critical Issues
inferred← citeshttps://doi.org/10.1007/978-0-387-68969-2_19openalex-snapshot
Cancer Immunotherapy: Perspectives and Prospects
inferred← citeshttps://doi.org/10.1007/978-0-387-77574-6_15openalex-snapshot
Melanoma and Nonmelanoma Skin Cancers and the Immune System
inferred← citeshttps://doi.org/10.1007/978-0-387-88611-4_22openalex-snapshot
How Best to Generate Dendritic Cells from Patients with Cancer and How Best to Use them for Immunotherapeutic Purposes
inferred← citeshttps://doi.org/10.1007/978-1-4020-9293-0_12openalex-snapshot
Impact of Tumour Cell Death on the Activation of Anti-tumour Immune Response
inferred← citeshttps://doi.org/10.1007/978-1-4419-0170-5_8openalex-snapshot
Modification of Dendritic Cells to Enhance Cancer Vaccine Potency
inferred← citeshttps://doi.org/10.1007/978-1-4614-0613-6_11openalex-snapshot
Clinical Trials of Invariant Natural Killer T Cell-Based Immunotherapy for Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4614-4732-0_4openalex-snapshot
Dendritic Cell-Based Cancer Immunotherapy: Achievements and Novel Concepts
inferred← citeshttps://doi.org/10.1007/978-1-4899-8056-4_11openalex-snapshot
IDO in Inflammatory Programming and Immune Suppression in Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4939-1417-3_13openalex-snapshot
Dendritic Cell-Based Vaccines
inferred← citeshttps://doi.org/10.1007/978-1-4939-3625-0_16openalex-snapshot
Immune Monitoring Using mRNA-Transfected Dendritic Cells
inferred← citeshttps://doi.org/10.1007/978-1-59745-001-0_6openalex-snapshot
The Immune System in the Pathogenesis of Vascular Proliferative Disease
inferred← citeshttps://doi.org/10.1007/978-1-59745-222-9_14openalex-snapshot
Cytokine Gene Therapy for Genitourinary Cancer
inferred← citeshttps://doi.org/10.1007/978-1-59745-395-0_2openalex-snapshot
Balancing Tolerance and Immunity
inferred← citeshttps://doi.org/10.1007/978-1-59745-409-4_11openalex-snapshot
Lentiviral Vector-Mediated Genetic Programming of Mouse and Human Dendritic Cells
inferred← citeshttps://doi.org/10.1007/978-1-60761-421-0_7openalex-snapshot
Generation of Stable Th1/CTL-, Th2-, and Th17-Inducing Human Dendritic Cells
inferred← citeshttps://doi.org/10.1007/978-1-60761-657-3_27openalex-snapshot
Immunotherapy of Cancer with Dendritic Cells Loaded with Tumor Antigens and Activated Through mRNA Electroporation
inferred← citeshttps://doi.org/10.1007/978-1-61779-539-8_21openalex-snapshot
Binding and Uptake of Candida albicans by Human Monocyte-Derived Dendritic Cells
inferred← citeshttps://doi.org/10.1007/978-1-61779-842-9_29openalex-snapshot
Minor Histocompatibility Antigen Typing by DNA Sequencing for Clinical Practice in Hematopoietic Stem-Cell Transplantation
inferred← citeshttps://doi.org/10.1007/978-1-62703-417-3_11openalex-snapshot
Dendritic Cells for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-031-14955-9_66-1openalex-snapshot
Functionalized Carbon Nanostructures for Smart Medical Implants
inferred← citeshttps://doi.org/10.1007/978-3-031-32150-4_66openalex-snapshot
Functionalized Carbon Nanostructures for Smart Medical Implants
inferred← citeshttps://doi.org/10.1007/978-3-0346-0136-8openalex-snapshot
Principles of Immunopharmacology
inferred← citeshttps://doi.org/10.1007/978-3-319-05104-8_8openalex-snapshot
Dendritic Cell-Based Cancer Vaccines
inferred← citeshttps://doi.org/10.1007/978-3-319-62431-0_14openalex-snapshot
Peptide-Based Therapeutic Cancer Vaccines
inferred← citeshttps://doi.org/10.1007/978-3-319-62870-7_56openalex-snapshot
The Influence of DCs Loaded with Tumor Antigens on the Cytotoxic Response of MNC Culture Patients with Oncology
inferred← citeshttps://doi.org/10.1007/978-3-319-94174-5_3openalex-snapshot
Bio-nano: Theranostic at Cellular Level
inferred← citeshttps://doi.org/10.1007/978-3-540-71029-5_15openalex-snapshot
Dendritic Cell-Based Immunotherapy in Myeloid Leukaemia: Translating Fundamental Mechanisms into Clinical Applications
inferred← citeshttps://doi.org/10.1007/978-3-662-47081-7_4openalex-snapshot
Molecular and Cellular Interplay in SCC Including Immunomodulation and Clinical Implications
inferred← citeshttps://doi.org/10.1007/978-4-431-79466-0_8openalex-snapshot
Dendritic Cell-based Immune Therapy: Concept, Design, Present Limitations, and Future Projections
inferred← citeshttps://doi.org/10.1007/978-94-007-4543-8_7openalex-snapshot
Liposomes and Other Nanoparticles as Cancer Vaccines and Immunotherapeutics
inferred← citeshttps://doi.org/10.1007/978-981-96-2407-2_155openalex-snapshot
Policy, Regulations, and Safety of Nanofillers in Environment
inferred← citeshttps://doi.org/10.1007/978-981-99-3516-1_155-1openalex-snapshot
Policy, Regulations, and Safety of Nanofillers in Environment
inferred← citeshttps://doi.org/10.1007/s00005-008-0033-2openalex-snapshot
Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer
inferred← citeshttps://doi.org/10.1007/s00018-012-1159-2openalex-snapshot
In vivo imaging of therapy-induced anti-cancer immune responses in humans
inferred← citeshttps://doi.org/10.1007/s00106-004-1201-2openalex-snapshot
Bedeutung dendritischer Zellen f�r die Immuntherapie von Tumorerkrankungen
inferred← citeshttps://doi.org/10.1007/s00259-005-1825-9openalex-snapshot
Biodistribution of radiolabelled human dendritic cells injected by various routes
inferred← citeshttps://doi.org/10.1007/s00262-004-0605-xopenalex-snapshot
New developments in dendritic cell?based vaccinations: RNA translated into clinics
inferred← citeshttps://doi.org/10.1007/s00262-005-0040-7openalex-snapshot
Dendritic cells are essential for priming but inefficient for boosting antitumour immune response in an orthotopic murine glioma model
inferred← citeshttps://doi.org/10.1007/s00262-005-0056-zopenalex-snapshot
A new dendritic cell vaccine generated with interleukin-3 and interferon-β induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients
inferred← citeshttps://doi.org/10.1007/s00262-006-0142-xopenalex-snapshot
In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line
inferred← citeshttps://doi.org/10.1007/s00262-006-0157-3openalex-snapshot
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
inferred← citeshttps://doi.org/10.1007/s00262-006-0161-7openalex-snapshot
Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells
inferred← citeshttps://doi.org/10.1007/s00262-006-0245-4openalex-snapshot
Antigen-independent immune responses after dendritic cell vaccination
inferred← citeshttps://doi.org/10.1007/s00262-007-0304-5openalex-snapshot
In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients
inferred← citeshttps://doi.org/10.1007/s00262-007-0334-zopenalex-snapshot
Current approaches in dendritic cell generation and future implications for cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s00262-007-0385-1openalex-snapshot
Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes
inferred← citeshttps://doi.org/10.1007/s00262-008-0553-yopenalex-snapshot
Dendritic cell vaccination and immune monitoring
inferred← citeshttps://doi.org/10.1007/s00262-008-0606-2openalex-snapshot
Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo
inferred← citeshttps://doi.org/10.1007/s00262-008-0626-yopenalex-snapshot
Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cells
inferred← citeshttps://doi.org/10.1007/s00262-009-0736-1openalex-snapshot
Killer dendritic cells and their potential for cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s00262-010-0833-1openalex-snapshot
Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s00262-010-0942-xopenalex-snapshot
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
inferred← citeshttps://doi.org/10.1007/s00262-012-1242-4openalex-snapshot
Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial
inferred← citeshttps://doi.org/10.1007/s00262-012-1263-zopenalex-snapshot
Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters
inferred← citeshttps://doi.org/10.1007/s00262-012-1334-1openalex-snapshot
Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation
inferred← citeshttps://doi.org/10.1007/s00262-014-1520-4openalex-snapshot
Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity
inferred← citeshttps://doi.org/10.1007/s00262-015-1746-9openalex-snapshot
Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets
inferred← citeshttps://doi.org/10.1007/s00262-016-1796-7openalex-snapshot
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity
inferred← citeshttps://doi.org/10.1007/s00262-018-2207-zopenalex-snapshot
Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma
inferred← citeshttps://doi.org/10.1007/s00262-019-02466-xopenalex-snapshot
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
inferred← citeshttps://doi.org/10.1007/s00268-005-7762-8openalex-snapshot
Active Antigen‐specific Immunotherapy of Melanoma: from Basic Science to Clinical Investigation
inferred← citeshttps://doi.org/10.1007/s00277-009-0721-yopenalex-snapshot
Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens
inferred← citeshttps://doi.org/10.1007/s00296-011-2133-2openalex-snapshot
Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives
inferred← citeshttps://doi.org/10.1007/s00384-012-1530-7openalex-snapshot
Synergistical toll-like receptors activated dendritic cells induce antitumor effects against carcinoembryonic antigen-expressing colon cancer
inferred← citeshttps://doi.org/10.1007/s00418-008-0531-7openalex-snapshot
Visualizing dendritic cell migration within the skin
inferred← citeshttps://doi.org/10.1007/s10238-011-0159-0openalex-snapshot
A phase I pilot trial of MUC1-peptide-pulsed dendritic cells in the treatment of advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s10529-011-0528-5openalex-snapshot
Lipopolysaccharide-stimulated activation of murine DC2.4 cells is attenuated by n-butylidenephthalide through suppression of the NF-κB pathway
inferred← citeshttps://doi.org/10.1007/s10719-007-9092-6openalex-snapshot
Surface α2-3- and α2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis
inferred← citeshttps://doi.org/10.1007/s10989-005-9270-yopenalex-snapshot
Dendritic Cell Immunotherapy of Hepatitis C Virus Infection: Toxicology of Lipopeptide-Loaded Dendritic Cells
inferred← citeshttps://doi.org/10.1007/s11060-020-03472-1openalex-snapshot
Bioengineered recombinant vault nanoparticles coupled with NY-ESO-1 glioma-associated antigens induce maturation of native dendritic cells
inferred← citeshttps://doi.org/10.1007/s11095-007-9443-9openalex-snapshot
Immune Cell Recruitment and Cell-Based System for Cancer Therapy
inferred← citeshttps://doi.org/10.1007/s11095-012-0849-7openalex-snapshot
RAFTsomes Containing Epitope-MHC-II Complexes Mediated CD4+ T Cell Activation and Antigen-Specific Immune Responses
inferred← citeshttps://doi.org/10.1007/s11307-017-1127-1openalex-snapshot
Optimization of Dendritic Cell-Mediated Cytotoxic T-Cell Activation by Tracking of Dendritic Cell Migration Using Reporter Gene Imaging
inferred← citeshttps://doi.org/10.1007/s11307-021-01647-4openalex-snapshot
In Vivo MRI Tracking of Tumor Vaccination and Antigen Presentation by Dendritic Cells
inferred← citeshttps://doi.org/10.1007/s11434-016-1038-6openalex-snapshot
Recent advances in the development of nanomaterials for DC-based immunotherapy
inferred← citeshttps://doi.org/10.1007/s11684-007-0003-9openalex-snapshot
Developing effective tumor vaccines: basis, challenges and perspectives
inferred← citeshttps://doi.org/10.1007/s11888-014-0250-5openalex-snapshot
Peptide Vaccines for Treatment of Colon Cancer: Have We Made Progress?
inferred← citeshttps://doi.org/10.1007/s11892-008-0020-3openalex-snapshot
Immunomodulation of autoimmune diabetes by dendritic cells
inferred← citeshttps://doi.org/10.1007/s12026-011-8224-zopenalex-snapshot
Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?
inferred← citeshttps://doi.org/10.1007/s12032-014-0202-6openalex-snapshot
Low expression of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in non-Hodgkin lymphoma and a significant correlation with β2-microglobulin
inferred← citeshttps://doi.org/10.1007/s12094-007-0016-5openalex-snapshot
Dendritic cells: still a promising tool for cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s12094-012-0854-7openalex-snapshot
Clinical safety of induced CTL infusion through recombinant adeno-associated virus-transfected dendritic cell vaccination in Chinese cancer patients
inferred← citeshttps://doi.org/10.1007/s12094-017-1657-7openalex-snapshot
Tyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s12094-024-03678-zopenalex-snapshot
The progress of tumor vaccines clinical trials in non-small cell lung cancer
inferred← citeshttps://doi.org/10.1007/s12185-013-1496-4openalex-snapshot
DC-based immunotherapy for hematological malignancies
inferred← citeshttps://doi.org/10.1007/s12253-013-9704-3openalex-snapshot
Autologous Dendritic Cell Based Adoptive Immunotherapy of Patients with Colorectal Cancer—A Phase I-II Study
inferred← citeshttps://doi.org/10.1007/s12307-012-0117-8openalex-snapshot
TNFSF15 Modulates Neovascularization and Inflammation
inferred← citeshttps://doi.org/10.1007/s13238-013-3916-xopenalex-snapshot
Enhancement of DC-mediated anti-leukemic immunity in vitro by WT1 antigen and CpG co-encapsulated in PLGA microparticles
inferred← citeshttps://doi.org/10.1007/s13277-016-4933-1openalex-snapshot
Identification of proteins derived from Listeria monocytogenes inducing human dendritic cell maturation
inferred← citeshttps://doi.org/10.1007/s40778-015-0024-2openalex-snapshot
Dendritic Cell Immune Therapy to Break or Induce Tolerance
inferred← citeshttps://doi.org/10.1016/b978-0-08-102983-1.00019-3openalex-snapshot
Lymph node targeting for improved potency of cancer vaccine
inferred← citeshttps://doi.org/10.1016/b978-0-12-370454-2.00003-xopenalex-snapshot
Interferon-producing killer dendritic cells (IKDC)
inferred← citeshttps://doi.org/10.1016/b978-0-12-381422-7.10016-1openalex-snapshot
Hematopoietic Stem Cell Properties, Markers, and Therapeutics
inferred← citeshttps://doi.org/10.1016/b978-0-12-386960-9.00003-4openalex-snapshot
Dendritic Cells Modified by Vitamin D: Future Immunotherapy for Autoimmune Diseases
inferred← citeshttps://doi.org/10.1016/b978-0-12-394295-1.00020-2openalex-snapshot
Dendritic Cell Vaccination
inferred← citeshttps://doi.org/10.1016/b978-0-12-394296-8.00032-4openalex-snapshot
IDO in Immune Escape
inferred← citeshttps://doi.org/10.1016/b978-0-12-394447-4.30006-2openalex-snapshot
Tumor Necrosis Factor Receptors: A Brief Digestion
inferred← citeshttps://doi.org/10.1016/b978-0-12-396548-6.00004-4openalex-snapshot
Experience with Synthetic Vaccines for Cancer and Persistent Virus Infections in Nonhuman Primates and Patients
inferred← citeshttps://doi.org/10.1016/b978-0-12-821618-7.00162-0openalex-snapshot
Tumor Necrosis Factor Receptors: A Brief Digestion
inferred← citeshttps://doi.org/10.1016/b978-0-323-85941-7.00010-3openalex-snapshot
Cancer vaccine’s multiverse and the future ahead
inferred← citeshttps://doi.org/10.1016/b978-0-443-21521-6.00008-9openalex-snapshot
Biomaterials-based strategies for cancer vaccines
inferred← citeshttps://doi.org/10.1016/b978-012088403-2/50003-4openalex-snapshot
Dendritic cells as targets and tools in vaccines
inferred← citeshttps://doi.org/10.1016/b978-012369410-2.50019-xopenalex-snapshot
Hematopoietic Stem Cell Properties, Markers, and Therapeutics
inferred← citeshttps://doi.org/10.1016/b978-012372551-6/50070-5openalex-snapshot
Immune Escape: Immunosuppressive Networks
inferred← citeshttps://doi.org/10.1016/b978-012372551-6/50083-3openalex-snapshot
Indoleamine 2,3-Dioxygenase in Immune Escape: Regulation and Therapeutic Inhibition
inferred← citeshttps://doi.org/10.1016/b978-1-4160-3611-1.50045-3openalex-snapshot
Therapeutic cancer vaccines
inferred← citeshttps://doi.org/10.1016/b978-1-4557-0090-5.00045-8openalex-snapshot
Therapeutic cancer vaccines
inferred← citeshttps://doi.org/10.1016/bs.mcb.2023.06.001openalex-snapshot
Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients
inferred← citeshttps://doi.org/10.1016/j.addr.2010.08.009openalex-snapshot
Imaging of cellular therapies
inferred← citeshttps://doi.org/10.1016/j.addr.2014.05.003openalex-snapshot
“In vitro” 3D models of tumor-immune system interaction
inferred← citeshttps://doi.org/10.1016/j.ajo.2014.07.014openalex-snapshot
Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients
inferred← citeshttps://doi.org/10.1016/j.archoralbio.2025.106252openalex-snapshot
Effect of intratumor dendritic cell vaccination with and without chemoradiation in induced oral squamous cell carcinoma of hamsters
inferred← citeshttps://doi.org/10.1016/j.arcmed.2013.11.007openalex-snapshot
Innate Immune System Cells in Atherosclerosis
inferred← citeshttps://doi.org/10.1016/j.bbcan.2014.07.005openalex-snapshot
Sweet escape: Sialic acids in tumor immune evasion
inferred← citeshttps://doi.org/10.1016/j.bbmt.2009.10.006openalex-snapshot
Partial T Cell-Depleted Allogeneic Stem Cell Transplantation following Reduced-Intensity Conditioning Creates a Platform for Immunotherapy with Donor Lymphocyte Infusion and Recipient Dendritic Cell Vaccination in Multiple Myeloma
inferred← citeshttps://doi.org/10.1016/j.bbrc.2011.05.026openalex-snapshot
Sialyl Lewisx-dependent binding of human monocyte-derived dendritic cells to selectins
inferred← citeshttps://doi.org/10.1016/j.beha.2008.07.010openalex-snapshot
Dendritic cell vaccines in acute leukaemia
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2011.05.013openalex-snapshot
Simultaneous in vivo tracking of dendritic cells and priming of an antigen-specific immune response
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2015.09.031openalex-snapshot
Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growth
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2020.120139openalex-snapshot
In vivo dynamic cell tracking with long-wavelength excitable and near-infrared fluorescent polymer dots
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2021.121180openalex-snapshot
A novel prodrug and its nanoformulation suppress cancer stem cells by inducing immunogenic cell death and inhibiting indoleamine 2, 3-dioxygenase
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2021.121297openalex-snapshot
Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2025.123294openalex-snapshot
STING-activating layered double hydroxide nano-adjuvants for enhanced cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.biopha.2020.110046openalex-snapshot
Dendritic cell vaccine for the effective immunotherapy of breast cancer
inferred← citeshttps://doi.org/10.1016/j.biopha.2023.114377openalex-snapshot
Comparison of tumor-derived total RNA and cell lysate on antitumor immune activity
inferred← citeshttps://doi.org/10.1016/j.cct.2007.07.002openalex-snapshot
Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trial
inferred← citeshttps://doi.org/10.1016/j.cellimm.2006.06.001openalex-snapshot
Immunophenotype and functions of fetal baboon bone-marrow derived dendritic cells
inferred← citeshttps://doi.org/10.1016/j.cellimm.2010.03.017openalex-snapshot
Exogenous dendritic cell homing to draining lymph nodes can be boosted by mast cell degranulation
inferred← citeshttps://doi.org/10.1016/j.cellimm.2011.08.001openalex-snapshot
Reduced efficacy of multiple doses of CpG-matured dendritic cell tumor vaccine in an experimental model
inferred← citeshttps://doi.org/10.1016/j.cellimm.2011.09.012openalex-snapshot
Cells with dendritic cell morphology and immunophenotype, binuclear morphology, and immunosuppressive function in dendritic cell cultures
inferred← citeshttps://doi.org/10.1016/j.cellimm.2016.10.004openalex-snapshot
Role of heterogeneous cell population on modulation of dendritic cell phenotype and activation of CD8 T cells for use in cell-based immunotherapies
inferred← citeshttps://doi.org/10.1016/j.clim.2006.06.009openalex-snapshot
IL-10 gene modified dendritic cells induced antigen-specific tolerance in experimental autoimmune myocarditis
inferred← citeshttps://doi.org/10.1016/j.clim.2011.01.009openalex-snapshot
Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer
inferred← citeshttps://doi.org/10.1016/j.coi.2005.01.004openalex-snapshot
Migration of dendritic cell based cancer vaccines: in vivo veritas?
inferred← citeshttps://doi.org/10.1016/j.coi.2005.01.010openalex-snapshot
Immunotherapy of cancer through targeting of minor histocompatibility antigens
inferred← citeshttps://doi.org/10.1016/j.coi.2005.02.003openalex-snapshot
Dendritic-cell-based therapeutic vaccination against cancer
inferred← citeshttps://doi.org/10.1016/j.coi.2013.03.001openalex-snapshot
Dendritic cell-based nanovaccines for cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2007.12.007openalex-snapshot
Dendritic cell vaccines in melanoma: From promise to proof?
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2012.09.014openalex-snapshot
Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2017.02.002openalex-snapshot
Radiotherapy in the age of cancer immunology: Current concepts and future developments
inferred← citeshttps://doi.org/10.1016/j.currproblcancer.2015.10.004openalex-snapshot
From concept to clinic: Mathematically informed immunotherapy
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2004.11.001openalex-snapshot
Tumor necrosis factor, cancer and anticancer therapy
inferred← citeshttps://doi.org/10.1016/j.ddstr.2008.03.004openalex-snapshot
Targeting the immune response in asthma
showing the first 200 of 895 · page through all 895
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.